Markets
The East Side of the US Capitol Building in the early morning, Washington DC, USA.
The east side of the US Capitol Building (Getty Images)

Health insurers rise after the Senate rejects competing healthcare plans

The Democratic plan would have extended tax credits, while the GOP plan would have replaced them with HSAs.

The US Senate rejected two competing healthcare plans as insurance premiums are set to skyrocket and the Biden-era enhanced Affordable Care Act tax credits are set to expire at year-end.

A Democratic proposal to extend the tax credits — which were at the center of the longest government shutdown in history — failed, as did the Republican plan, which would have allowed ACA subsidies to lapse and partially replace them with federally funded tax-advantaged health savings accounts.

The biggest providers of ACA Marketplace plans like Oscar Health, UnitedHealthcare, Molina Healthcare, Elevance Health, and Centene rose after the vote. While the potential end of the ACA subsidies would hurt their bottom lines, investors have had time to price that in, while the Senate GOP plan to replace that funding with HSA contributions presented a new threat.

The ACA tax credits, which subsidize health insurance plans provided by private insurers, were part of a 2021 COVID-19 relief package passed by a Democratic-controlled Congress. The subsidies, which are set to expire on December 31, led to a boom in ACA enrollment.

The tax credits are set to end just as ACA Marketplace premium payments are expected to double next year, according to an estimate from KFF.

More Markets

See all Markets
markets

SpaceX gets a wave of bullish ratings from Wall Street analysts

SpaceX received more than a dozen positive analyst calls on Tuesday — including from major Wall Street banks — as they initiate coverage on Elon Musk’s space and AI company.

SpaceX went public on June 12 at a $2.2 trillion valuation, the largest debut in history. While the company hasn’t yet posted a profit, it seems to have convinced Wall Street that it will get there and grow its valuation on the way.

Of the at least 17 analysts that gave a rating on Tuesday, all but one gave it a “buy” or “outperform” rating. MoffettNathanson was "neutral."

The ratings come as SpaceX joined the Nasdaq 100 index, a benchmark tech-heavy basket of companies that underpins millions of portfolios. The inclusion adds built-in demand for the stock from index funds and ETFs.

Still, SpaceX fell more than 5% on Tuesday amid a broader sell-off, and is currently effectively flat from its opening price of $150 a share.

Latest Stories

Sherwood Media, LLC and Chartr Limited produce fresh and unique perspectives on topical financial news and are fully owned subsidiaries of Robinhood Markets, Inc., and any views expressed here do not necessarily reflect the views of any other Robinhood affiliate, including Robinhood Markets, Inc., Robinhood Financial LLC, Robinhood Securities, LLC, Robinhood Crypto, LLC, Robinhood Money, LLC, Robinhood U.K. Ltd, Robinhood Derivatives, LLC, Robinhood Gold, LLC, Robinhood Asset Management, LLC, Robinhood Credit, Inc., Robinhood Ventures DE, LLC and, where applicable, its managed investment vehicles.